首页 正文

Miglustat does not impact clinical progression in patients with spastic paraplegia type 11

{{output}}
Spastic paraplegia type 11 (SPG11) is a progressive neurological condition with no treatment. Possible involvement of abnormal ganglioside metabolism has been reported in mouse and human cells. Preclinical data in zebrafish and fruit fly models of the disease ... ...